Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RaeSedo
AddedFeb 17, 2024
UpdatedJun 18, 2026
RaeSedo

RaeSedo

Arizona-based RaeSedo develops optimized peptidomimetics for asthma treatment using innovative software.

HQ
Arizona, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

RaeSedo, based in Arizona, is dedicated to developing optimized peptidomimetics for the treatment of asthma. Utilizing innovative software, the company focuses on generating and improving structural peptidomimetics to offer new therapeutic options for asthma patients. RaeSedo's mission is to address the severe impact of asthma, which affects millions globally, by creating effective and advanced treatments.

Key achievements include securing SSTR funding for a Phase I proposal led by Drs. Monica Kraft and Julie Ledford. This funding supports the development of new, short peptide derivatives and mimetics aimed at improving asthma treatment outcomes. RaeSedo's work has the potential to significantly impact the lives of asthma patients by providing more effective therapeutic solutions.

RaeSedo - Similar Companies

Areteia Therapeutics logo

Areteia Therapeutics

areteiatx.com

Asepha logo

Asepha

asepha.ai

Aster logo

Aster

astercare.com

Aero Therapeutics logo

Aero Therapeutics

Pantherics logo

Pantherics

pantherics.com

Osia Medical logo

Osia Medical

Ritten logo

Ritten

AZmed logo

AZmed

azmed.co

Endue logo

Endue

enduesoftware.com

R&A Data logo

R&A Data

rna-data.com

One Step Software logo

One Step Software

Aristea Therapeutics logo

Aristea Therapeutics

Darwin logo

Darwin

projectdarwin.xyz

Aerwave Medical logo

Aerwave Medical

aerwavemed.com

AsthmaMD logo

AsthmaMD

asthmamd.org

RaeSedo - Quick Facts

Who are RaeSedo's competitors?

Companies similar to RaeSedo include Areteia Therapeutics, Asepha, Aster and Aero Therapeutics.

When was RaeSedo founded?

RaeSedo was founded in 2019.

Where is RaeSedo's headquarters located?

RaeSedo's headquarters is located in Arizona, US.

When was RaeSedo's last funding round?

RaeSedo's most recent funding round was for $3.4M (USD) in November 2022.

How much has RaeSedo raised to-date?

As of Nov 16, 2022, RaeSedo has raised a total of $3.5M (USD).

How many employees does RaeSedo have?

RaeSedo has 5 employees as of Feb 4, 2024.

RaeSedo - Classification

Technology
  • Software
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Asthma Treatment
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software